Quantitative angiogenesis in breast cancer.

Area of Science:

• Oncology
• Pathology
• Biomedical Engineering

Background:

• Tumor growth relies on neovascularization, involving processes like angiogenesis, vasculogenesis, and vascular remodeling.
• Traditional methods for quantifying tumor vasculature often use factor VIII-related antigen immunohistochemistry.
• Newer, more objective methods are needed to accurately assess tumor vascularity.

Purpose of the Study:

• To review recent advances in understanding tumor neovascularization mechanisms.
• To discuss improved quantitative methods for assessing tumor vascularity, including CD34 and Chalkley graticule.
• To outline potential alternative measures of angiogenic activity in breast tumors.

Main Methods:

• Review of current literature on tumor neovascularization mechanisms.
• Discussion of immunohistochemistry techniques using CD34 and factor VIII-related antigen.
• Explanation of quantitative assessment tools like the Chalkley eyepiece graticule.
• Exploration of alternative markers for angiogenic activity.

Main Results:

• Solid tumors utilize diverse vascularization strategies including angiogenesis, vasculogenesis, co-option, intussusception, and vascular mimicry.
• CD34 antibody and Chalkley graticule enhance the objectivity and sensitivity of tumor vascularity assessment.
• Variations in protocols exist for assessing vascularity in different contexts, such as in situ breast disease.
• Other measures like angiogenic factors, endothelial cell proliferation, and hypoxic markers offer further insights.

Conclusions:

• Significant progress has been made in understanding tumor neovascularization.
• Objective and sensitive methods for assessing tumor vascularity are crucial for diagnosis and treatment.
• A range of markers and techniques can be employed to evaluate the angiogenic potential of tumors.